NEW YORK (GenomeWeb) – Agilent Technologies reported after the close of the market Tuesday that its revenues for the first quarter were flat year over year.

For the three months ended Jan. 31, Agilent recorded $1.03 billion in revenues, beating the average Wall Street estimate of $1.02 billion.

"Agilent delivered a strong start to the year," Agilent President and CEO Mike McMullen said in a statement. "Revenue and earnings per share exceeded our guidance range, reflecting the strength of Agilent's products, services, and relationships with customers in our markets."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Helix customers can purchase apps that interpret different aspects of their genome, Technology Review reports.

The New York Times reports that a number of companies and research institutes are pursuing gene therapies.

Salmon with shorter telomeres survive to make the trip back to their river homes, New Scientist reports.

In PLOS this week: vaginal microbiome composition, population patterns of Chagas-carrying Rhodnius ecuadoriensis, and more.